Logo-BCC-Research.jpg
Human Microbiome Drugs and Diagnostics to Reach US$10B by 2024
14 juin 2017 05h00 HE | BCC Research
WELLESLEY, Mass., June 14, 2017 (GLOBE NEWSWIRE) -- Emerging therapies and treatments that explore the human microbiome are moving from labs to doctor’s offices, with potential to reach $9.9...